Introduction The development of molecularly targeted anticancer therapies and
immunotherapy continues to revolutionize the treatment of cancer. FDA accelerated …

This review aims to provide an understanding of the diagnostic and therapeutic challenges
of uveitis associated with immune checkpoint inhibitors (ICI). In the wake of these molecules …

Introduction Almost one-quarter of immune checkpoint inhibitor (ICI) recipients experience
sicca syndrome, while Sjögren's disease (SjD) is estimated at 0.3-2.5%, possibly …

Given the consequences of immune-mediated ocular adverse drug reactions, clinicians
must be aware of these to facilitate early recognition and management. The prompt …

Purpose Conjunctival melanoma is a rare neoplasm with high rates of recurrence and
metastasis. Traditional management includes surgical excision and cryotherapy, followed by …

Immunotherapy has renovated the field of oncology. Usually, cancer is treated by surgery,
chemotherapy, and radiation. Immunotherapy is a promising treatment that harnesses the …

Scleritis and episcleritis are rare ocular inflammatory diseases but deserve to be known by
internists because of their frequent association with systemic autoimmune diseases. It is …

Purpose To describe various clinical pictures of posterior scleritis following pembrolizumab
therapy for metastatic cutaneous melanoma. Methods Description of the clinical case with …

Purpose: To describe various clinical pictures of posterior scleritis following pembrolizumab
therapy for metastatic cutaneous melanoma. Methods: Description of the clinical case with …

Despite ocular adverse events from immune checkpoint inhibitors being uncommon, they
are still important complications to be aware of. We present the case of metastatic melanoma …